Home › Kidney Failure › NCT03032835

Partners Calciphylaxis Biobank

Partners Calciphylaxis Biobank and Patient Registry

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

1. Male or female ≥18 years old
2. Skin lesions consistent with calciphylaxis diagnosis as determined by the treating clinician
3. Informed of the investigational nature of the study and sign written Informed consent OR are eligible for surrogate consent process based on impaired decision making

Exclusion Criteria:

1. Patients \<18 years of age
2. Prisoners

About the study

Calciphylaxis, a vascular calcification disorder, is a rare and serious disorder characterized by calcification of dermal arterioles.

There are significant gaps in the understanding of the pathophysiology and risk factors for calciphylaxis. At present, there is no effective treatment. Uncertain pathobiology, rare incidence and lack of collaborative approach have been some of the major limiting factors towards treating calciphylaxis.

The Partners Calciphylaxis Biorepository (PCB) aims to address these gaps within calciphylaxis research by utilizing existing and, when necessary, developing new infrastructure to support the consent of patients and the collection of dedicated samples for a calciphylaxis repository.

Sponsor: Massachusetts General Hospital · Participants: 300 · Started: 2017-01

Contact the study team

• Sagar U Nigwekar, MD, MMSc · Phone: 617-726-7872

Official record on ClinicalTrials.gov — NCT03032835

Locations in the U.S.

Conditions

• Kidney Failure
• Chronic Kidney Disease

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.